Cellular metabolism constrains innate immune responses in early human ontogeny

Nat Commun. 2018 Nov 16;9(1):4822. doi: 10.1038/s41467-018-07215-9.

Abstract

Pathogen immune responses are profoundly attenuated in fetuses and premature infants, yet the mechanisms underlying this developmental immaturity remain unclear. Here we show transcriptomic, metabolic and polysome profiling and find that monocytes isolated from infants born early in gestation display perturbations in PPAR-γ-regulated metabolic pathways, limited glycolytic capacity and reduced ribosomal activity. These metabolic changes are linked to a lack of translation of most cytokines and of MALT1 signalosome genes essential to respond to the neonatal pathogen Candida. In contrast, they have little impact on house-keeping phagocytosis functions. Transcriptome analyses further indicate a role for mTOR and its putative negative regulator DNA Damage Inducible Transcript 4-Like in regulating these metabolic constraints. Our results provide a molecular basis for the broad susceptibility to multiple pathogens in these infants, and suggest that the fetal immune system is metabolically programmed to avoid energetically costly, dispensable and potentially harmful immune responses during ontogeny.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • B-Cell CLL-Lymphoma 10 Protein / deficiency
  • B-Cell CLL-Lymphoma 10 Protein / genetics
  • B-Cell CLL-Lymphoma 10 Protein / immunology
  • CARD Signaling Adaptor Proteins / deficiency
  • CARD Signaling Adaptor Proteins / genetics
  • CARD Signaling Adaptor Proteins / immunology
  • Candida albicans / immunology
  • Candida parapsilosis / immunology
  • Gene Expression Regulation, Developmental*
  • Humans
  • Immunity, Innate*
  • Infant, Newborn
  • Infant, Premature
  • Interleukins / deficiency
  • Interleukins / genetics
  • Interleukins / immunology
  • Lectins, C-Type / deficiency
  • Lectins, C-Type / genetics
  • Lectins, C-Type / immunology
  • Lipopolysaccharides / pharmacology
  • Microarray Analysis
  • Monocytes / cytology
  • Monocytes / drug effects
  • Monocytes / immunology*
  • Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein / deficiency
  • Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein / genetics
  • Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein / immunology*
  • PPAR gamma / deficiency
  • PPAR gamma / genetics
  • PPAR gamma / immunology*
  • Primary Cell Culture
  • Protein Biosynthesis / immunology
  • TOR Serine-Threonine Kinases / deficiency
  • TOR Serine-Threonine Kinases / genetics
  • TOR Serine-Threonine Kinases / immunology
  • Transcription Factors / deficiency
  • Transcription Factors / genetics
  • Transcription Factors / immunology*
  • Transcriptome / immunology
  • Tumor Necrosis Factor-alpha / deficiency
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • B-Cell CLL-Lymphoma 10 Protein
  • BCL10 protein, human
  • CARD Signaling Adaptor Proteins
  • CARD9 protein, human
  • CLEC7A protein, human
  • DDIT4 protein, human
  • Interleukins
  • Lectins, C-Type
  • Lipopolysaccharides
  • PPAR gamma
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • MALT1 protein, human
  • Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein